1a/1b Study of OPT101 First in Human Study Assessing Safety and Tolerability of 15-mer Peptide.

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
This is a first-in-human study, Phase 1, randomized, placebo-controlled, double blinded study that will be conducted in 2 parts.
Epistemonikos ID: e082ed1f900aa10a4ed72fd3cfd76486e61a1625
First added on: Oct 02, 2023